Evidence map›Paper›PMID 35990084›Full record

SynthesisFrontiers in psychiatry2022

Duration of the effectiveness of nicotine electronic cigarettes on smoking cessation and reduction: Systematic review and meta-analysis.

Paul Vanderkam, Audrey Bonneau, Shérazade Kinouani, Palina Dzeraviashka, Philippe Castera, Marc Besnier, Philippe Binder, Nicolas Doux, Nematollah Jaafari, Claire Lafay-Chebassier

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 6 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 6 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Pooled it
  4. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  5. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2024
    Pooled it
  6. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2022
    Pooled it
  7. Trial
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Paul VanderkamINSERM U-1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers, Poitiers, France.
Audrey BonneauDepartment of General Practice, Poitiers, France.
Shérazade KinouaniBordeaux Population Health Research Center, Univ. Bordeaux, Inserm, Team HEALTHY, UMR 1219, Bordeaux, France.
Palina DzeraviashkaDepartment of General Practice, University of Bordeaux, Bordeaux, France.
Philippe CasteraDepartment of General Practice, University of Bordeaux, Bordeaux, France.
Marc BesnierDepartment of General Practice, Poitiers, France.
Philippe BinderDepartment of General Practice, Poitiers, France.
Nicolas DouxService Commun de Documentation, Bibliothèque Universitaire de Médecine et de Pharmacie, University of Poitiers, Poitiers, France.
Nematollah JaafariClinic Research Unit, Centre Hospitalier Henri Laborit, Poitiers, France.
Claire Lafay-ChebassierINSERM U-1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers, Poitiers, France.
Université de Poitiers · FRUniversité de Bordeaux · FRLaboratoire de Neurosciences Expérimentales et CliniquesCentre Hospitalier Henri Laborit · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The success of pharmacotherapies for smoking cessation in real-life remains limited, with a significant number of long-term relapses. Despite first promising results, the duration of the effectiveness of electronic cigarettes is still unknown. Our objective was to assess the duration of the effectiveness of electronic cigarettes on smoking cessation and reduction in daily smokers. Methods: The databases EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), ClinicalTrials.gov and PUBMED were consulted until March 23, 2022. We selected only randomized controlled trials with daily adult smokers. The intervention was the nicotinic electronic cigarette Results: Abstinence at the end of the intervention and follow-up periods was significantly higher in the nicotine electronic cigarette group, compared to nicotine replacement therapy (NRT) [respectively: RR: 1.37 (CI 95%: 1.32-2.93) and RR: 1.49 (CI 95%: 1.14-1.95)] and to the non-nicotine electronic cigarette condition [respectively: RR: 1.97 (CI 95%: 1.18-2.68) and RR: 1.66 (CI 95%: 1.01-2.73)]. With regard to smoking reduction, the electronic cigarette with nicotine is significantly more effective than NRT at the end of the intervention and follow-up periods [respectively RR: 1.48 (CI 95%: 1.04-2.10) and RR: 1.47 (CI 95%: 1.18-1.82)] and non-nicotine electronic cigarette in the long term [RR: 1.31 (CI 95%: 1.02-1.68)]. Conclusions: This meta-analysis shows the duration of the effectiveness of the nicotine electronic cigarette

Indexed as

electronic cigarettes (E-cigarettes)Electronic Nicotine Delivery Systems (ENDS)serious adverse effectssmoking cessationsmoking reduction

Identifiers

PMID35990084
PMCPMC9386078
OpenAlexW4289730855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.